Announcements Trials
Browse Landscape

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Leukemia 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Lymphoma 22Leukemia, Myeloid, Acute 22Myelodysplastic Syndromes 21Breast Neoplasms 18Lymphoma, Non-Hodgkin 16Central Nervous System Neoplasms 14Burkitt Lymphoma 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Leukemia, Lymphocytic, Chronic, B-Cell 11Multiple Myeloma 10Leukemia, Myeloid, Accelerated Phase 10Hodgkin Disease 10Dendritic Cell Sarcoma, Interdigitating 10Lymphoma, Large-Cell, Immunoblastic 9Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Follicular 9Leukemia, Myeloid, Chronic-Phase 9Leukemia, Biphenotypic, Acute 9Brain Neoplasms 9Blast Crisis 9Neuroblastoma 8Medulloblastoma 8Lymphoma, Mantle-Cell 8Recurrence 7Lymphoma, B-Cell, Marginal Zone 7Hematologic Neoplasms 7Ovarian Neoplasms 6Congenital Abnormalities 6

Interventions

fludarabine 2fludarabine phosphate 1Thiotepa 1Photopheresis 1Melphalan 1Clofarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hemoglobinopathies × Thiotepa × Clear all
NCT03609840 2023-09-21

Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Completed
25 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡